Simulations Plus, Inc. Announces Quarterly Dividend of $0.06 (NASDAQ:SLP)

Simulations Plus, Inc. (NASDAQ:SLP) declared a quarterly dividend on Wednesday, April 3rd, Zacks reports. Investors of record on Monday, April 29th will be given a dividend of 0.06 per share by the technology company on Monday, May 6th. This represents a $0.24 annualized dividend and a yield of 0.51%. The ex-dividend date of this dividend is Friday, April 26th.

Simulations Plus has a dividend payout ratio of 29.6% meaning its dividend is sufficiently covered by earnings.

Simulations Plus Stock Performance

SLP opened at $46.65 on Thursday. Simulations Plus has a 52-week low of $32.69 and a 52-week high of $52.69. The stock has a market capitalization of $932.53 million, a P/E ratio of 88.02 and a beta of 0.72. The company’s 50-day simple moving average is $43.52 and its two-hundred day simple moving average is $40.95.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Wednesday, April 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. Simulations Plus had a return on equity of 7.95% and a net margin of 16.22%. The business had revenue of $18.31 million during the quarter, compared to the consensus estimate of $17.31 million. During the same period in the previous year, the company posted $0.20 EPS. The business’s quarterly revenue was up 16.2% compared to the same quarter last year. Research analysts forecast that Simulations Plus will post 0.67 EPS for the current fiscal year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 18,945 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $38.02, for a total transaction of $720,288.90. Following the completion of the sale, the director now owns 3,641,250 shares of the company’s stock, valued at $138,440,325. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $39.94, for a total value of $798,800.00. Following the completion of the transaction, the director now directly owns 3,600,195 shares in the company, valued at $143,791,788.30. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Walter S. Woltosz sold 18,945 shares of the stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $38.02, for a total transaction of $720,288.90. Following the completion of the sale, the director now directly owns 3,641,250 shares of the company’s stock, valued at $138,440,325. The disclosure for this sale can be found here. 20.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Separately, Craig Hallum upped their target price on shares of Simulations Plus from $50.00 to $51.00 and gave the company a “buy” rating in a report on Thursday, January 4th.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.